 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LivaNova (NASDAQ:LIVN  Get Free Report)s stock had its buy rating restated by stock analysts at Mizuho in a report released on Wednesday, Benzinga reports. They presently...

Mizuho Reiterates "Buy" Rating for LivaNova (NASDAQ:LIVN)

Shares of LivaNova PLC (NASDAQ:LIVN  Get Free Report) saw an uptick in trading volume on Wednesday . 296,173 shares were traded during mid-day trading, a decline of 49% from the previous...

LivaNova (NASDAQ:LIVN) Sees Unusually-High Trading Volume

This is a Bullish indicator signaling LIVN's price could rise from here. Traders may explore going long the stock or buying call options...

LivaNova (LIVN, $56.28) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 21, 2024

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time (8 a.m...

LivaNova to Announce First-Quarter 2024 Results

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

LivaNova jumps nearly 12% after saying  trial likely to meet primary endpoint

LivaNova PLC (NASDAQ:LIVN  Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 296,173 shares changed hands during mid-day trading, a decline of 49% from the...

LivaNova (NASDAQ:LIVN) Sees Large Volume Increase

Check out David Einhorn Stock Picks &raquo;

 Download GuruFolio Report of David Einhorn (Updated on 03/19/2024), Check out PRIMECAP Management Stock Picks &raquo;

 Download GuruFolio Report of...

What's Driving LivaNova PLC's Surprising 11% Stock Rally?

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation, has...

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

Tudor Investment Corp Et Al cut its stake in shares of LivaNova PLC (NASDAQ:LIVN  Free Report) by 60.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and...

Tudor Investment Corp Et Al Has $2.50 Million Position in LivaNova PLC (NASDAQ:LIVN)

In trading on Thursday, shares of LivaNova PLC (LIVN) crossed below their 200 day moving average of 51.18, changing hands as low as 51.12 per share. LivaNova PLC shares are currently...

LIVN Crosses Below Key Moving Average Level

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Volume (M)	5,177.00
52-Wk High	$59.86
52-Wk Low	$42.75

LIVN LivaNova PLC

About

Feed

News

Sentiment

Earnings

Fundamentals